Xenikos’ €40 Million Convertible Debt Financing

NautaDutilh and Goodwin Procter LLP advised Xenikos on the deal.Xenikos B.V., a clinical-stage biopharmaceutical company currently developing a novel therapy for treating immune related disorders, announced…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now